Business
Amgen announces a recommended public cash offer to the shareholders of Nuevolution
THOUSAND OAKS, Calif., May 21, 2019 /PRNewswire/ -- The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or
About this update from Amgen Inc.
[{"type":"text","content":"THOUSAND OAKS, Calif., May 21, 2019 /PRNewswire/ --\nThe Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. \nShareholders in the United States should refer to the section entitled \"Important Information to U.S. Shareholders\" at the end of this press release.\nAmgen Inc. (\"Amgen\") (NASDAQ:AMGN) today announces a recommended public cash offer to the shareholders of Nuevolution AB (publ) (\"Nuevolution\") to tender all their shares in Nuevolution to Amgen (the \"Offer\"). Nuevolution's shares are listed on Nasdaq Stockholm, Small Cap.\nThe Offer in brief\nAmgen offers SEK 32.50 in cash for each share in Nuevolution (the \"Offer Price\").(1) The total value of the Offer amounts to approximately SEK 1,610 million, which corresponds to approximately USD 167 million.(2)The Offer does not include warrants issued by Nuevolution to participants under the incentive programs implemented by Nuevolution. Amgen will offer the participants a fair treatment in connection with the Offer. Amgen may acquire, or enter into arrangements to acquire, shares in Nuevolution (or any securities that are convertible into, exchangeable for or exercisable for such shares) outside the Offer. Any purchases made or arranged will be in accordance with Swedish law and Nasdaq Stockholm's Takeover Rules (the \"Takeover Rules\") and will be disclosed in accordance with applicable rules. The Offer represents a premium of: 169% compared to the closing price of Nuevolution's shares on Nasdaq Stockholm on 21 May 2019 (the last trading day prior to the announcement of the Offer), of SEK 12.10; 69% compared to the highest trading price of Nuevolution's shares on Nasdaq Stockholm during the 52-week period up to and including 21 May 2019 (the last trading day prior to the announcement of the Offer), of SEK 19.28; and 166% compared to the volume-weighted average price of Nuevolution...